Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical trials. Founder of Myeloma Crowd, Myeloma Crowd Radio and the CrowdCare Foundation.
SIGN UP FOR OUR NEWSLETTER
Get the latest thought leadership on multiple myeloma delivered straight to your inbox.
– – – January is Myeloma Crowd Month! In the coming weeks, we are highlighting each of our programs and how they can help you in your myeloma journey. Learn more about what we do and if you run into a question or concerns, please email email@example.com.
Cardiff University researchers have discovered a new a new type of T cell that can kill a variety of cancers, with the hope of creating a general “one-size-fits-all” T cell therapy. CAR T cell therapy today is commonly “customized” for each cancer patient using their own T cells. A patient has their immune system cells […]
An antibody drug conjugate is a type of immunotherapy being explored in multiple myeloma. Glaxo-Smith Klein is developing a new antibody drug conjugate in myeloma called Belantamab mafodotin (or “belmaf” for short). These drugs use the immune system to find the right myeloma-specific target and then drop a toxic payload in a targeted way. At […]